IN2014DE00193A - - Google Patents
Info
- Publication number
- IN2014DE00193A IN2014DE00193A IN193DE2014A IN2014DE00193A IN 2014DE00193 A IN2014DE00193 A IN 2014DE00193A IN 193DE2014 A IN193DE2014 A IN 193DE2014A IN 2014DE00193 A IN2014DE00193 A IN 2014DE00193A
- Authority
- IN
- India
- Prior art keywords
- arthritis
- collagen
- administration
- relates
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361895332P | 2013-10-24 | 2013-10-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DE00193A true IN2014DE00193A (es) | 2015-05-01 |
Family
ID=51610711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN193DE2014 IN2014DE00193A (es) | 2013-10-24 | 2014-01-21 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9066926B2 (es) |
| KR (1) | KR101664290B1 (es) |
| AR (1) | AR095104A1 (es) |
| AU (1) | AU2014202041B8 (es) |
| BR (1) | BR112014011741A2 (es) |
| CA (1) | CA2846644C (es) |
| CL (1) | CL2014001281A1 (es) |
| CO (1) | CO7020846A2 (es) |
| IN (1) | IN2014DE00193A (es) |
| MX (1) | MX347669B (es) |
| MY (1) | MY180106A (es) |
| PH (1) | PH12014501453A1 (es) |
| SG (1) | SG11201403524RA (es) |
| WO (1) | WO2015060888A1 (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10226513B2 (en) | 2015-01-09 | 2019-03-12 | Mark Terrell Smith | Method and composition to prevent or improve symptoms of musculoskeletal distress degeneration |
| US20180078768A1 (en) * | 2016-09-16 | 2018-03-22 | Boston Scientific Neuromodulation Corporation | Method and apparatus for pain management using heart sounds |
| EP3518736B1 (en) | 2016-09-27 | 2021-08-18 | Boston Scientific Neuromodulation Corporation | System for pain management using objective pain measure |
| US10610688B2 (en) | 2016-09-27 | 2020-04-07 | Boston Scientific Neuromodulation Corporation | Systems and methods for closed-loop pain management |
| US11793217B1 (en) | 2016-10-04 | 2023-10-24 | Lonza Greenwood Llc | Method of manufacture and pasteurization of products containing undenatured collagen |
| WO2018071639A1 (en) | 2016-10-12 | 2018-04-19 | Advanced Biomatrix, Inc. | Three-dimensional (3-d) printing inks made from natural extracellular matrix molecules |
| US10667747B2 (en) | 2016-10-25 | 2020-06-02 | Boston Scientific Neuromodulation Corporation | Method and apparatus for pain control using baroreflex sensitivity during posture change |
| WO2018132529A1 (en) | 2017-01-11 | 2018-07-19 | Boston Scientific Neuromodulation Corporation | Pain management based on brain activity monitoring |
| US11089997B2 (en) | 2017-01-11 | 2021-08-17 | Boston Scientific Neuromodulation Corporation | Patient-specific calibration of pain quantification |
| US10631776B2 (en) | 2017-01-11 | 2020-04-28 | Boston Scientific Neuromodulation Corporation | Pain management based on respiration-mediated heart rates |
| EP3568861A1 (en) | 2017-01-11 | 2019-11-20 | Boston Scientific Neuromodulation Corporation | Pain management based on emotional expression measurements |
| US10631777B2 (en) | 2017-01-11 | 2020-04-28 | Boston Scientific Neuromodulation Corporation | Pain management based on functional measurements |
| US10729905B2 (en) | 2017-01-11 | 2020-08-04 | Boston Scientific Neuromodulation Corporation | Pain management based on muscle tension measurements |
| US10960210B2 (en) | 2017-02-10 | 2021-03-30 | Boston Scientific Neuromodulation Corporation | Method and apparatus for pain management with sleep detection |
| CN106713191B (zh) * | 2017-02-28 | 2020-09-08 | 西安电子科技大学 | 一种多级搜索sage方法 |
| CN107048412A (zh) * | 2017-04-26 | 2017-08-18 | 北京盛美诺生物技术有限公司 | 一种含有ⅱ型胶原蛋白的咀嚼型产品 |
| EP3936185A1 (en) | 2017-07-18 | 2022-01-12 | Boston Scientific Neuromodulation Corporation | Sensor-based pain management systems and methods |
| JP2020531587A (ja) * | 2017-08-21 | 2020-11-05 | ロンザ，エルエルシー | 組成物およびそれから作られた栄養サプリメント |
| WO2019046735A1 (en) | 2017-08-31 | 2019-03-07 | Lonza Inc. | HEALTH PROMOTING COMPOSITION AND METHODS OF USING COMPLEMENT-RELATED APPLICATIONS |
| IT201700111939A1 (it) * | 2017-10-05 | 2019-04-05 | Jointherapeutics S R L | Composizione farmaceutica per l’uso nel trattamento di stati infiammatori |
| BR112021000860A2 (pt) * | 2018-07-16 | 2021-04-13 | Lonza Consumer Health Inc. | Suplemento de colágeno e matéria celular e método para administrar o mesmo |
| WO2021016665A1 (en) * | 2019-07-30 | 2021-02-04 | Atp Institute Pty Ltd | A gummy composition |
| WO2021067452A1 (en) | 2019-09-30 | 2021-04-08 | Lonza Consumer Health Inc. | Cannabinoid product for improving musculoskeletal health |
| US20230248808A1 (en) | 2020-01-29 | 2023-08-10 | Lonza Greenwood Llc | Joint Health Composition and Use Thereof in Healthy Mammals |
| MX2022010745A (es) | 2020-03-03 | 2022-11-08 | Lonza Greenwood Llc | Colageno tipo ii sin desnaturalizar en aplicaciones de alimentos y bebidas y usos de este. |
| MX2022010859A (es) | 2020-03-24 | 2022-11-08 | Lonza Greenwood Llc | Colageno tipo ii sin desnaturalizar en alimentos y golosinas para animales. |
| US20230256060A1 (en) | 2020-06-12 | 2023-08-17 | Lonza Greenwood Llc | Undenatured Type II Collagen as a Supplement for Improved Endurance, Lipid Metabolism, and Oxidative Stress |
| US20230284668A1 (en) * | 2020-08-19 | 2023-09-14 | Lonza Consumer Health Inc. | Method for Improving Inflammation, Joint Health, Joint Mobility, and Joint Comfort in Healthy Mammals |
| CN115120618B (zh) * | 2021-03-23 | 2024-01-26 | 安徽盛美诺生物技术有限公司 | 具有改善免疫应答作用的软骨提取物、其制备方法及其用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399347A (en) | 1987-06-24 | 1995-03-21 | Autoimmune, Inc. | Method of treating rheumatoid arthritis with type II collagen |
| WO1993008784A1 (en) | 1991-11-08 | 1993-05-13 | Gunilla Lofgren Nisser | Partially occluded contact lens for treating visual and/or brain disorder |
| US5529786A (en) | 1994-02-28 | 1996-06-25 | Moore; Eugene R. | Process and product for treatment of rheumatoid arthritis |
| US5645851A (en) | 1994-02-28 | 1997-07-08 | Moore; Eugene R. | Product for alleviating the symptons of arthritis in mammals |
| US5637321A (en) | 1994-02-28 | 1997-06-10 | Moore; Eugene R. | Method for preparing animal tissue for use in alleviating the symptoms of arthritis in mammals |
| US6162787A (en) * | 1999-04-02 | 2000-12-19 | Immudyne, Inc. | Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions |
| US6372794B1 (en) | 1999-08-26 | 2002-04-16 | Marcel E. Nimni | Method for alleviating arthritis in mammals |
| US20020086070A1 (en) | 2000-03-11 | 2002-07-04 | Kuhrts Eric Hauser | Anti-inflammatory and connective tissue repair formulations |
| US7083820B2 (en) | 2000-09-29 | 2006-08-01 | Schilling Marvin L | Method for producing biologically active products |
| JP2003048850A (ja) | 2001-06-01 | 2003-02-21 | Nippon Meat Packers Inc | 関節傷害治療剤及び機能性食品 |
| US20060062859A1 (en) * | 2004-08-05 | 2006-03-23 | Kenneth Blum | Composition and method to optimize and customize nutritional supplement formulations by measuring genetic and metabolomic contributing factors to disease diagnosis, stratification, prognosis, metabolism, and therapeutic outcomes |
| FR2900155B1 (fr) * | 2006-04-21 | 2008-06-27 | Diana Naturals Sa | Hydrolisat de cartilage aviaire, procede d'obtention et utilisations |
| US20100215731A1 (en) | 2009-02-20 | 2010-08-26 | Maastricht University | Method for improving cartilage repair and/or preventing cartilage degeneration in a joint |
| US20110218151A1 (en) | 2010-03-04 | 2011-09-08 | Joar Opheim | Substances for promoting healthy joint function comprising omega-3 polyunsaturated fatty acids or drivatives thereof, undenatured type ii collagen and, optionally, glucosamine sulfate |
| CN101822684B (zh) | 2010-05-27 | 2012-08-15 | 江苏江山制药有限公司 | 用于防治骨关节痛的复方组合制剂及其制备方法 |
| US20120294898A1 (en) | 2011-05-19 | 2012-11-22 | Warsaw Orthopedic, Inc. | Injectable dbm for soft tissue repair |
| CN102423487B (zh) | 2011-12-23 | 2014-04-16 | 内蒙古伊利实业集团股份有限公司 | 一种骨关节保健组合物及其应用 |
| CN103203012A (zh) | 2012-01-12 | 2013-07-17 | 深圳市麦金利实业有限公司 | 关节保健品 |
-
2014
- 2014-01-13 WO PCT/US2014/011303 patent/WO2015060888A1/en active Application Filing
- 2014-01-13 SG SG11201403524RA patent/SG11201403524RA/en unknown
- 2014-01-13 AU AU2014202041A patent/AU2014202041B8/en active Active
- 2014-01-13 BR BR112014011741A patent/BR112014011741A2/pt not_active Application Discontinuation
- 2014-01-13 MY MYPI2014001885A patent/MY180106A/en unknown
- 2014-01-13 MX MX2014002934A patent/MX347669B/es active IP Right Grant
- 2014-01-13 KR KR1020147010693A patent/KR101664290B1/ko active IP Right Grant
- 2014-01-13 US US14/153,841 patent/US9066926B2/en active Active
- 2014-01-13 CA CA2846644A patent/CA2846644C/en active Active
- 2014-01-21 IN IN193DE2014 patent/IN2014DE00193A/en unknown
- 2014-01-29 CO CO14018154A patent/CO7020846A2/es unknown
- 2014-01-30 AR ARP140100320A patent/AR095104A1/es unknown
- 2014-05-15 CL CL2014001281A patent/CL2014001281A1/es unknown
- 2014-06-24 PH PH12014501453A patent/PH12014501453A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201403524RA (en) | 2015-05-28 |
| KR20150059132A (ko) | 2015-05-29 |
| CA2846644A1 (en) | 2015-07-13 |
| AU2014202041B2 (en) | 2019-11-28 |
| AU2014202041B8 (en) | 2020-04-02 |
| WO2015060888A1 (en) | 2015-04-30 |
| CA2846644C (en) | 2018-05-01 |
| MX2014002934A (es) | 2015-09-21 |
| MX347669B (es) | 2017-05-08 |
| CL2014001281A1 (es) | 2015-10-30 |
| AR095104A1 (es) | 2015-09-30 |
| PH12014501453B1 (en) | 2015-01-21 |
| MY180106A (en) | 2020-11-23 |
| KR101664290B1 (ko) | 2016-10-11 |
| US9066926B2 (en) | 2015-06-30 |
| US20150119335A1 (en) | 2015-04-30 |
| PH12014501453A1 (en) | 2015-01-21 |
| BR112014011741A2 (pt) | 2017-05-30 |
| AU2014202041A1 (en) | 2015-05-14 |
| CO7020846A2 (es) | 2014-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DE00193A (es) | ||
| CY1123065T1 (el) | Ανασυνδυασμενα προβιοτικα βακτηριδια | |
| MX2018012166A (es) | Dosificacion oral de compuestos peptido similar al glaucon-1 (glp-1). | |
| GB201711353D0 (en) | Improvements relating to face recognition | |
| UA110813C2 (uk) | Лікування ліподистрофії | |
| MX2015014500A (es) | Terapia de combinacion de anticuerpos contra csf-1r y agonista de tlr9. | |
| ECSP15043422A (es) | Un procedimiento para aumentar la formacion de acido piroglutamico de una proteina | |
| MX2018004831A (es) | Metodos para confeccionar formas fucosiladas y afucosiladas de una proteina. | |
| EA201791110A1 (ru) | Сублингвальное введение рилузола | |
| PH12016500598A1 (en) | Protoxin-ii variants and methods of use | |
| MY190747A (en) | Method for producing silazane-siloxane copolymers and the use of such copolymers | |
| EA201692534A1 (ru) | Способы лечения гипотонии | |
| EA201690855A1 (ru) | Эндоглиновые пептиды для лечения фиброзных заболеваний | |
| MX2015013066A (es) | Usos terapéuticos para anticuerpos contra vegfr1. | |
| MX359181B (es) | Hidrolizado de colágeno y uso del mismo. | |
| EA201690075A1 (ru) | Способ лечения внутриклеточной инфекции | |
| MX2016012758A (es) | Composicion hiperosmolar de acido hialuronico. | |
| MX2016005545A (es) | Analogo de la relaxina humana, composicion farmaceutica del mismo y aplicacion farmaceutica del mismo. | |
| EA201690446A1 (ru) | Лечение множественной миеломы | |
| MX2016005645A (es) | Composicion farmaceutica topica de acitretina. | |
| EA201691036A1 (ru) | Новое соединение для лечения тяжелой гипогликемии | |
| EA201690914A1 (ru) | Новое соединение для лечения тяжелой гипогликемии | |
| EA201690445A1 (ru) | Лечение рака | |
| MX2015017880A (es) | Método para el tratamiento y/o prevención contra encefalopatia traumática cronica grado i. | |
| MX2015011881A (es) | Proceso para la preparacion de 3,7-dimetilnonan-1-ol. |